NCT06161090View on ClinicalTrials.gov

Study of CM310 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
Healthy
Interventions
BIOLOGICAL

CM310

CM310 injection

DRUG

Placebo

subcutaneous injection

Trial Locations (1)

Unknown

PKUCare Luzhong Hospital, Zibo

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06161090 - Study of CM310 in Healthy Subjects | Biotech Hunter | Biotech Hunter